Product Description
Product Name: Bevatas 400 Solution for Infusion
Active Ingredient: Bevacizumab
Strength: 400 mg/16 mL
Form: Solution for Intravenous Infusion
Category: Anticancer / Monoclonal Antibody / Anti-VEGF Agent
Indication: Colorectal Cancer, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Glioblastoma, Ovarian Cancer, Cervical Cancer
Bevatas 400 Solution for Infusion contains Bevacizumab, a recombinant monoclonal antibody that targets vascular endothelial growth factor (VEGF). It is used in the treatment of several advanced cancers by inhibiting angiogenesis—the formation of new blood vessels that supply nutrients and oxygen to tumors—thereby restricting tumor growth and progression.
